25 years since the Human Genome Project scientists have broken the $1000 genome and CRISPR gets a simplification upgrade.
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
Boston-based clinical screening company receives European seal of approval for breast and ovarian cancer test
This week FLG Content Manager, Liz Harley, considers the real and imaginary consequences of genomic apps. We’re prone to the occasional flight of fancy in the FLG office. I think it comes from working in field with such an exciting, and potentially terrifying future. This week, following the announcement that Illumina are giving consumer genomics the […]
Dean Schorno, former CFO of Adaptive Technologies Corp, joins 23andMe amid plans to relaunch health-focused products.
Editas Medicine raises more funds to develop CRISPR-Cas9 for clinical application.